Navigation Links
Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis

age in Germany has actinic keratosis, the incidence doubles every 10 years. We will develop the 10 % formulation further for the treatment of this unusually frequent disease and intend to bring it to registration by 2009," commented Prof. Dr. Hermann Lübbert, CEO of Biofrontera AG.

About Biofrontera AG Biofrontera AG is specialized in the development of pharmaceutical products in the area of dermatology. The company is characterized by a broad, relatively close to the market product portfolio and a solid liquidity. Biofrontera is listed in the regulated market of the Düsseldorf stock exchange under the symbol B8F and the ISIN number DE0006046113. http://www.biofrontera.com/

This press release contains forward-looking statements based on the currently held beliefs and assumptions of the management of Biofrontera AG, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the assumptions expressed or implied in this press release to be faulty. Given these risks, uncertainties and other factors, recipients of this document are cautioned not to place undue reliance on the forward-looking statements. Biofrontera AG disclaims any obligation to update these forward-looking statements to reflect future events or developments.

For further information please contact:

Anke zur Mühlen Corporate Communication

+ 49 (0) 214 87632 22 + 49 (0) 214 87632 90 a.zurmuehlen@biofrontera.com

Biofrontera AG Hemmelrather Weg 201 D- 51377 Leverkusen, Germany


'"/>




Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:7/29/2014)... 2014 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China , ... quarter 2014 financial results on Tuesday, August 5, 2014 ... management will hold a conference call at 8:00 a.m. ... p.m., Beijing Time on August 6, 2014, to discuss ...
(Date:7/29/2014)... 29, 2014 , Next ... development program has commenced , TPM®/Oxycodone Phase ... during Q4 2014 , TPM®/Oxymorphone Phase 2 ... 1H 2015 Australian drug delivery company, Phosphagenics ... transdermal patch programs after its recent announcement of a $19.2 million ...
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
Breaking Medicine Technology:China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... Fla., Sept. 27, 2011 Nuance Health today announced ... conducted on their innovative product, Swype Cold & Flu ... The clinical study, conducted on 103 volunteers ... the effectiveness, tolerability, and willingness of participants to use ...
... China, Sept. 27, 2011 /PRNewswire-Asia/ -- China Health Resource, ... Chinese Medicine (TCM) products, announced robust quarterly earnings for ... and $1.7 million in net income, 443% increase from ... of about $0.02 per share for the first half ...
Cached Medicine Technology:Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study 2China Health Resource, Inc. Announces Record 2nd Quarter 2011 Results 2China Health Resource, Inc. Announces Record 2nd Quarter 2011 Results 3
(Date:7/29/2014)... (PRWEB) July 29, 2014 This month, ... “The Building Blocks to a Successful, Balanced Career.” The ... their professional path, seeking guidance on creating a successful ... it’s built from focus, determination, and understanding your strengths ... Therapy Changes. “This guide will uncover the elements to ...
(Date:7/29/2014)... Boca Raton, FL (PRWEB) July 29, 2014 ... will officially launch its products in the UK in September. ... company’s products will be available Sept. 7 on Amazon.co.uk. , ... has been growing and we are truly looking forward to ... Amazon.co.uk will include OZ Naturals bestselling Vitamin C serum ...
(Date:7/29/2014)... According to the new market research report, "Fingerprint ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile ... & Finance), and Geography - Global Trends & ... the global Fingerprint Sensors Market is projected to ... high CAGR of 16.8% from 2014 to 2020. ...
(Date:7/29/2014)... 2014 The report “Cloud Database ... (Database Application Builder, Data Scaling and Replication, Back-Up ... Dbaas) and Service Models (Public Cloud, Private Cloud, ... (Small And Medium, Large) - Global Advancements, Market ... global cloud database and DBaaS market into various ...
(Date:7/29/2014)... people can handle stressful situations better than others, ... identical twins show differences in how they respond. ... in the brains of genetically identical mice that ... stressful situations. , The findings, published July ... help researchers prevent potential consequences of chronic stress ...
Breaking Medicine News(10 mins):Health News:Therapy Changes Releases New Guide to Building a Successful Career 2Health News:OZ Naturals to Launch Its Products in the UK 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 5Health News:A new brain-based marker of stress susceptibility 2
... between mothers and fathers may help protect children who ... a new study suggests. , Researchers found that supportive ... and attention levels what researchers call effortful control. ... of aggressive behavior and other forms of "acting out" ...
... the Convenience of a Computer, www.CardioCareLive.com takes place entirely online ... 8:00 PM Eastern.,Patch Adams, MD, the real physician behind the movie ... for free, visit cardioCareLive.com. , ... Needham, MA (PRWEB) ...
... partnership with the Forum, Unveil Disease "Hot Spots" - ... - an alliance of patient advocates, dialysis ... quality of care for individuals with kidney disease and ... the racial disparity among those suffering from Chronic Kidney ...
... and Sole Stroll June 14 Registration Underway, On-lineBALTIMORE, March ... Prince George,s Counties now have an angel on their ... that funds services to improve the quality of life ... The Red Devils network in the suburban D.C. area ...
... USA National Memory Champion Chester Santos Trains to Defend ... individuals who can memorize 99 faces and names, two ... 1,000 random digits in a matter of minutes. Chester ... successfully complete these memory challenges, among others, when he ...
... Highland Good Steward Management ("HGSM") today announced it ... investment adviser, as a sub adviser to Highland ... HGSM focuses on incorporating environmental, social ... William "Doug" Douglass III, co-founder of K2, said, ...
Cached Medicine News:Health News:Supportive co-parenting may reduce some child behavior problems 2Health News:Supportive co-parenting may reduce some child behavior problems 3Health News:CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today 2Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 2Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 3Health News:Red Devils Expand Into Suburban DC, Receive National Komen Grant 2Health News:The Making of a Memory Champion 2Health News:The Making of a Memory Champion 3Health News:K2 Advisors Named Investment Advisor by Highland Good Steward Management 2
... Manual Rack is a manual Modified ... erythrocyte sedimentation rate (ESR) of whole ... Streck ESR-Vacuum Tubes. The rack will ... The ESR-10 Manual Rack exhibits >96% ...
... verify automatic pipets without purchasing equipment or interrupting ... contains six vials of Receiver Solution and one ... pipet or dilutor to be verified, the technologist ... returned to Streck for analysis and calculation of ...
... assayed control for immunophenotyping with Beckman Coulter® ... the accuracy and reproducibility of all the ... including red blood cell lysis. Reference values ... lymphocytes, B lymphocytes, granulocytes, monocytes, and NK ...
... Cyto-Chex BCT is a vacuum tube ... whole blood samples for immunophenotyping by flow ... maintains the integrity of the white blood ... up to seven days. Patient samples collected ...
Medicine Products: